WELCOME TO WiNNOVA

MEDICAL | PHARACEUTICAL | HEALTHCARE

WiNNOVA are an international operation guide, marketing for medical and pharmaceutical components and services. We represent companies from all over the world, who distinguish themselves by innovative products and services.

Our customer base are companies in Europe and Asia, mainly in the area of medical and pharmaceutical industry, but also companies producing industrial applications.

WiNNOVA are also a UK healthcare consultancy which leading solutions provider committed to providing unique and innovative solutions delivering exceptional results. We build a unique business platform and network to offer a broad range of initiatives, using our expert problem solving skills, to enable clients to maximise their opportunities.

We consider each project individually so that the right solution is developed in order to meet our clients’ needs and exceed expectations.

Learn More

Home: Welcome

SERVICES

FIND OUT MORE ABOUT WHAT WE DO

THE UKCA MARK REPRENSENTATIVE

The UK has left the EU and the transition period after Brexit comes to an end of 2020.

The UKCA (UK Conformity Assessed) marking is a new UK product marking that will be used for goods being placed on the market in Great Britain (England, Wales and Scotland). It covers most goods such as Medical Devices which previously required the CE marking. The UKCA marking alone cannot be used for goods placed on the Northern Ireland market, which require the CE marking or UK(NI) marking.

From 1st January 2021 the technical requirements (essential requirements) must meet and the conformity assessment processes and standards that can be used to demonstrate conformity will be largely the same as they are now. The UKCA marking can be used from 1st January 2021. However, to allow business time to adjust to the new requirements, you will still be able to use the CE marking until 1 January 2022 in most cases. The CE marking will only be valid in Great Britain for areas where GB and EU rules remain the same. If the EU changes its rules and CE mark your product on the basis of those new rules you will not able to use the CE marking to sell in Great Britain even before 31 December 2021.

On behalf of the manufacture the UKCA authorised representative may deal with UK MHRA regulatory authorities regarding Declaration of Conformity, UKCA labelling and some special rules, incident reporting, notification performance for clinical investigation, Free Sales Certificates or Certificates of Marketability as well as Certificates of product registration.

Winnova is your competent regulatory partner for the successful marketing of your medical products in the UK.

MARKET INTELLIGENCE AND ANALYSIS

WiNNOVA has partnered with private and public sector organisations to gather and analyse market intelligence. We have supported accurate and confident decision-making in determining market opportunity, market penetration and market development strategies for organisations from the healthcare to the pharmaceutical sector.

Our unparalleled network and rigorous approach has ensured that organisations are armed with the most accurate and reflective market information.

THIS IN-DEPTH APPROACH SUPPORTS ORGANISATIONAL STRATEGY AT MULTIPLE STAGES:

Product Pre-Launch
Corporate
New Product Service Development
Tactical Marketing
PR

The purpose of incorporating market intelligence into the business intelligence process is to provide decision makers with a more “comprehensive picture” of ongoing performance in a set of given market conditions. This 'true' picture can only be complete by reaching the core market stakeholders.

METHODOLOGY INCLUDES:

Primary and Secondary Research
Desk Research | To Identify Gaps in Existing Service Offerings
Interviews | One-on-One
Focus Groups | Insight Meetings
Surveys | Web and Paper Based
Data Analysis | Assessing Information, Gap Analysis.

We adopt both qualitative and quantitative research models in order to collate and analyse the information keeping a focus on the research objectives.

Strategic Insight/Reporting | Finding Potential Gaps.

BUSINESS ENGAGEMENT

WiNNOVA'S core strength lies in helping healthcare organisations to fully understand the market area targeted in order to discover methods to add value and help place their business at the centre of their approach. The objective is to explore new and innovative partnerships and initiatives where the needs of the clients and the industry coincide.

To achieve this, we locate and bring together industry experts to discuss the programme objectives, formulate a strategy, identify potential gaps in the existing services/pathways, and devise an implementation plan.

ENGAGEMENT PROCESS:

Advisory Board Meetings | From Conception to Meet Evaluation-National and Regional Meetings
Steering Group Meetings
Building and Maintaining Main Support
Managing Networks and Cooperation Partner
Ladder of Adoption
Identification of ‘Rising Stars’
Interactions | Knowledge Sharing Platform

WORK WITH START-UPS AND SMEs

WiNNOVA has also partnered with private Investment Company to build up the potential start-ups investment platform; we help you to searching the right and potential company for your short and long term investment in the UK. Before going into how investors can make money through equity crowd funding, it is important to note that most start-up companies fail, and when this happens a company is unlikely to be able to pay back its investors (wholly or partially), let alone offer them any kind of profit on their investment.

One should never invest more than they are prepared to lose...

A report by NESTA showed that business angels who invested businesses industries they knew something about, and who created a portfolio of investments (not putting all their eggs in one basket, so to speak), were more likely to see a return from their investments.

It generally takes between 3-7 years for a company to sink or swim (failures usually happen earlier than successes).

There are three main ways that an investor can see a return on their investment:

DIVIDENDS | The company sometimes pays a percentage of their yearly profits to shareholders
TRADE SALE | The company is sold to another company for a lump sum, which is divided
proportionally between shareholders
PUBLIC OFFERING (IPO) | The company is so successful that it is listed on a stock exchange and shareholders can sell their shares at a price determined by public demand

Home: SERVICES

Home: CONTACT

CONTACT

WiNNOVA OFFICES
Unit 1-6 Southchurch Business Park

327 Southchurch Road

Southend on Sea

Essex

SS1 2PE
United Kingdom

info@winnova.co.uk

+44 (0)7919 285828 | +44 (0)1702 904008